908 Devices (NASDAQ:MASS) Announces Earnings Results, Beats Expectations By $0.03 EPS

908 Devices (NASDAQ:MASS - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.32) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.03, Zacks reports. 908 Devices had a negative net margin of 109.11% and a negative return on equity of 24.60%. The firm had revenue of $18.82 million during the quarter, compared to analyst estimates of $17.05 million. 908 Devices updated its FY 2025 guidance to EPS.

908 Devices Trading Down 8.3 %

908 Devices stock traded down $0.25 during mid-day trading on Friday, hitting $2.76. The stock had a trading volume of 1,417,648 shares, compared to its average volume of 3,913,927. 908 Devices has a one year low of $1.81 and a one year high of $7.56. The firm has a market capitalization of $96.11 million, a P/E ratio of -1.56 and a beta of 0.99. The firm's 50 day moving average is $2.51 and its 200 day moving average is $2.94.

Analyst Ratings Changes

MASS has been the subject of a number of research reports. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of 908 Devices in a report on Wednesday, February 19th. Stephens restated an "overweight" rating and issued a $6.00 price objective on shares of 908 Devices in a research note on Wednesday, January 15th. Stifel Nicolaus lowered their target price on 908 Devices from $17.00 to $6.00 and set a "buy" rating on the stock in a research report on Wednesday, November 13th. Leerink Partnrs cut 908 Devices from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, November 13th. Finally, Leerink Partners reaffirmed a "market perform" rating and issued a $4.00 price objective (down previously from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $5.33.

Remove Ads

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.